Yang, Jiuling
University of Michigan · U-M Rogel Cancer Center
3 papers on CoChatORCID 0000-0002-5301-6976
Most cited papers
- Verified
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression
Li, Y., Yang, J., Aguilar, A., McEachern, D., Przybranowski, S., Liu, L., Yang, C.-Y., Wang, M., Han, X., & Wang, S. (2019) · Journal of Medicinal Chemistry
Protein Degradation and InhibitorsCancer-related Molecular Pathways
Cited by 312
- Verified
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression
Qin, C., Hu, Y., Zhou, B., Fernandez-Salas, E., Yang, C.-Y., Liu, L., McEachern, D., Przybranowski, S., Wang, M., Stuckey, J., et al. (2018) · Journal of Medicinal Chemistry
Protein Degradation and InhibitorsChemical Synthesis and Analysis
Cited by 281
- Verified
Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders
Yang, J., Li, Y., Aguilar, A., Liu, Z., Yang, C.-Y., & Wang, S. (2019) · Journal of Medicinal Chemistry
Protein Degradation and InhibitorsChemical Synthesis and Analysis
Cited by 190
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free